A combined molecular‐pathologic score improves risk stratification of thyroid papillary microcarcinoma

Abstract

BRAF status together with several histopathologic features allowed clinical risk stratification of TPMCs. The combined MP risk stratification model was a better predictor of extrathyroid tumor spread than either mutation or histopathologic findings alone.